Bausch Health Companies (BHC) Current Deferred Tax Assets (2010 - 2015)
Bausch Health Companies (BHC) reported Current Deferred Tax Assets of $727.2 million for Q3 2015, up 129.84% on a YoY basis from $316.4 million in Q3 2014, and up 2.22% sequentially from $711.4 million in Q2 2015.
Bausch Health Companies (BHC) Current Deferred Tax Assets (2010 - 2015) Analysis & Trends
Bausch Health Companies (BHC) has 6 years of Current Deferred Tax Assets data on file, last reported at $727.2 million in Q3 2015.
- For the quarter ending Q3 2015, Current Deferred Tax Assets rose 129.84% year-over-year to $727.2 million; the trailing twelve-month figure through Sep 2015 stood at $727.2 million (up 129.84% YoY), and the FY2014 full-year result was $193.3 million, down 47.32% from the prior year.
- Current Deferred Tax Assets improved to $727.2 million in Q3 2015, from $711.4 million in the prior quarter.
- In the past five years, Current Deferred Tax Assets ranged from a high of $727.2 million in Q3 2015 to a low of $77.5 million in Q3 2011.
- A 5-year average of $255.6 million and a median of $196.8 million in 2012 frame the typical range for Current Deferred Tax Assets.
- Across the five-year window, Current Deferred Tax Assets jumped 540.48% in 2011 and plunged 47.32% in 2014, its largest moves.
- Tracing BHC's Current Deferred Tax Assets over 5 years: stood at $148.5 million in 2011, then surged by 31.36% to $195.0 million in 2012, then soared by 88.15% to $366.9 million in 2013, then tumbled by 47.32% to $193.3 million in 2014, then soared by 276.2% to $727.2 million in 2015.
- Business Quant data shows BHC's Current Deferred Tax Assets at $727.2 million in Q3 2015, $711.4 million in Q2 2015, and $193.3 million in Q4 2014.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Bausch Health Companies | 1.66 Bn | 1.33 Bn | 2.52 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 727.20 Mn |
| Sep 30, 2015 | 727.20 Mn |
| Jun 30, 2015 | 711.40 Mn |
| Jun 30, 2015 | 711.40 Mn |
| Dec 31, 2014 | 193.30 Mn |
| Dec 31, 2014 | 193.30 Mn |
| Sep 30, 2014 | 316.40 Mn |
| Sep 30, 2014 | 316.40 Mn |
| Jun 30, 2014 | 309.80 Mn |
| Jun 30, 2014 | 309.80 Mn |
| Mar 31, 2014 | 315.30 Mn |
| Mar 31, 2014 | 315.30 Mn |
| Dec 31, 2013 | 366.90 Mn |
| Dec 31, 2013 | 366.90 Mn |
| Sep 30, 2013 | 221.93 Mn |
| Sep 30, 2013 | 221.93 Mn |
| Jun 30, 2013 | 198.67 Mn |
| Jun 30, 2013 | 198.67 Mn |
| Mar 31, 2013 | 198.88 Mn |
| Mar 31, 2013 | 198.88 Mn |